www.bioagilytix.com
Open in
urlscan Pro
141.193.213.21
Public Scan
Submitted URL: http://www.bioagilytix.com/
Effective URL: https://www.bioagilytix.com/
Submission: On February 07 via manual from PH — Scanned from DE
Effective URL: https://www.bioagilytix.com/
Submission: On February 07 via manual from PH — Scanned from DE
Form analysis 4 forms found in the DOM
GET https://www.bioagilytix.com
<form class="elementor-search-form" role="search" action="https://www.bioagilytix.com" method="get">
<div class="elementor-search-form__toggle">
<i aria-hidden="true" class="fas fa-search"></i> <span class="elementor-screen-only">Search</span>
</div>
<div class="elementor-search-form__container">
<input placeholder="Search..." class="elementor-search-form__input" type="search" name="s" title="Search" value="">
<div class="dialog-lightbox-close-button dialog-close-button">
<i aria-hidden="true" class="eicon-close"></i> <span class="elementor-screen-only">Close</span>
</div>
</div>
</form>GET https://www.bioagilytix.com
<form class="elementor-search-form" role="search" action="https://www.bioagilytix.com" method="get">
<div class="elementor-search-form__container">
<div class="elementor-search-form__icon">
<i aria-hidden="true" class="fas fa-search"></i> <span class="elementor-screen-only">Search</span>
</div>
<input placeholder="Search..." class="elementor-search-form__input" type="search" name="s" title="Search" value="">
</div>
</form>POST /#wpcf7-f3894-p2614-o2
<form action="/#wpcf7-f3894-p2614-o2" method="post" class="wpcf7-form init" aria-label="Contact form" novalidate="novalidate" data-status="init">
<div style="display: none;">
<input type="hidden" name="_wpcf7" value="3894">
<input type="hidden" name="_wpcf7_version" value="5.7.3">
<input type="hidden" name="_wpcf7_locale" value="en_US">
<input type="hidden" name="_wpcf7_unit_tag" value="wpcf7-f3894-p2614-o2">
<input type="hidden" name="_wpcf7_container_post" value="2614">
<input type="hidden" name="_wpcf7_posted_data_hash" value="">
</div>
<div class="SpeakToScientistForm">
<div class="formFields">
<p><span class="wpcf7-form-control-wrap" data-name="FirstName"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" placeholder="First Name*" value="" type="text"
name="FirstName"></span><br>
<span class="wpcf7-form-control-wrap" data-name="LastName"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" placeholder="Last Name*" value="" type="text"
name="LastName"></span>
</p>
</div>
<div class="formFields">
<p><span class="wpcf7-form-control-wrap" data-name="Email"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-email wpcf7-validates-as-required wpcf7-validates-as-email" aria-required="true" aria-invalid="false" placeholder="Email*"
value="" type="email" name="Email"></span><br>
<span class="wpcf7-form-control-wrap" data-name="PhoneNumber"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" placeholder="Phone Number*" value="" type="text"
name="PhoneNumber"></span>
</p>
</div>
<div class="formFields">
<p><span class="wpcf7-form-control-wrap" data-name="Company"><input size="40" class="wpcf7-form-control wpcf7-text" aria-invalid="false" placeholder="Company" value="" type="text" name="Company"></span><br>
<span class="wpcf7-form-control-wrap" data-name="Title"><input size="40" class="wpcf7-form-control wpcf7-text" aria-invalid="false" placeholder="Title" value="" type="text" name="Title"></span>
</p>
</div>
<div class="formFields">
<p><span class="wpcf7-form-control-wrap" data-name="StateProvince"><select class="wpcf7-form-control wpcf7-select" aria-invalid="false" name="StateProvince">
<option value="">—Please choose an option—</option>
<option value="Alabama">Alabama</option>
<option value="Alaska">Alaska</option>
<option value="Alberta">Alberta</option>
<option value="Arkansas">Arkansas</option>
<option value="British Columbia">British Columbia</option>
<option value="California">California</option>
<option value="Colorado">Colorado</option>
<option value="Connecticut">Connecticut</option>
<option value="Delaware">Delaware</option>
<option value="District Of Columbia">District Of Columbia</option>
<option value="Florida">Florida</option>
<option value="Georgia">Georgia</option>
<option value="Hawaii">Hawaii</option>
<option value="Idaho">Idaho</option>
<option value="Illinois">Illinois</option>
<option value="Indiana">Indiana</option>
<option value="Iowa">Iowa</option>
<option value="Kansas">Kansas</option>
<option value="Kentucky">Kentucky</option>
<option value="Louisiana">Louisiana</option>
<option value="Maine">Maine</option>
<option value="Manitoba">Manitoba</option>
<option value="Maryland">Maryland</option>
<option value="Massachusetts">Massachusetts</option>
<option value="Michigan">Michigan</option>
<option value="Minnesota">Minnesota</option>
<option value="Mississippi">Mississippi</option>
<option value="Missouri">Missouri</option>
<option value="Montana">Montana</option>
<option value="Nebraska">Nebraska</option>
<option value="Nevada">Nevada</option>
<option value="New Brunswick">New Brunswick</option>
<option value="New Hampshire">New Hampshire</option>
<option value="New Jersey">New Jersey</option>
<option value="New Mexico">New Mexico</option>
<option value="New York">New York</option>
<option value="Newfoundland">Newfoundland</option>
<option value="North Carolina">North Carolina</option>
<option value="North Dakota">North Dakota</option>
<option value="Northwest Territories">Northwest Territories</option>
<option value="Nova Scotia">Nova Scotia</option>
<option value="Nunavut">Nunavut</option>
<option value="Ohio">Ohio</option>
<option value="Oklahoma">Oklahoma</option>
<option value="Ontario">Ontario</option>
<option value="Oregon">Oregon</option>
<option value="Pennsylvania">Pennsylvania</option>
<option value="Prince Edward Island">Prince Edward Island</option>
<option value="Quebec">Quebec</option>
<option value="Rhode Island">Rhode Island</option>
<option value="Saskatchewan">Saskatchewan</option>
<option value="South Carolina">South Carolina</option>
<option value="South Dakota">South Dakota</option>
<option value="Tennessee">Tennessee</option>
<option value="Texas">Texas</option>
<option value="Utah">Utah</option>
<option value="Vermont">Vermont</option>
<option value="Virginia">Virginia</option>
<option value="Washington">Washington</option>
<option value="West Virginia">West Virginia</option>
<option value="Wisconsin">Wisconsin</option>
<option value="Wyoming">Wyoming</option>
<option value="Yukon">Yukon</option>
</select></span><span class="wpcf7-form-control-wrap" data-name="Country"><select class="wpcf7-form-control wpcf7-select" aria-invalid="false" name="Country">
<option value="">—Please choose an option—</option>
<option value="Aruba">Aruba</option>
<option value="Afghanistan">Afghanistan</option>
<option value="Angola">Angola</option>
<option value="Albania">Albania</option>
<option value="Andorra">Andorra</option>
<option value="United Arab Emirates">United Arab Emirates</option>
<option value="Argentina">Argentina</option>
<option value="Armenia">Armenia</option>
<option value="American Samoa">American Samoa</option>
<option value="Antigua and Barbuda">Antigua and Barbuda</option>
<option value="Australia">Australia</option>
<option value="Austria">Austria</option>
<option value="Azerbaijan">Azerbaijan</option>
<option value="Burundi">Burundi</option>
<option value="Belgium">Belgium</option>
<option value="Benin">Benin</option>
<option value="Burkina Faso">Burkina Faso</option>
<option value="Bangladesh">Bangladesh</option>
<option value="Bulgaria">Bulgaria</option>
<option value="Bahrain">Bahrain</option>
<option value="Bahamas">Bahamas</option>
<option value="Bosnia and Herzegovina">Bosnia and Herzegovina</option>
<option value="Belarus">Belarus</option>
<option value="Belize">Belize</option>
<option value="Bermuda">Bermuda</option>
<option value="Bolivia, Plurinational State of">Bolivia, Plurinational State of</option>
<option value="Brazil">Brazil</option>
<option value="Barbados">Barbados</option>
<option value="Brunei Darussalam">Brunei Darussalam</option>
<option value="Bhutan">Bhutan</option>
<option value="Botswana">Botswana</option>
<option value="Central African Republic">Central African Republic</option>
<option value="Canada">Canada</option>
<option value="Switzerland">Switzerland</option>
<option value="Chile">Chile</option>
<option value="China">China</option>
<option value="Côte d'Ivoire">Côte d'Ivoire</option>
<option value="Cameroon">Cameroon</option>
<option value="Congo, the Democratic Republic of the">Congo, the Democratic Republic of the</option>
<option value="Congo">Congo</option>
<option value="Cook Islands">Cook Islands</option>
<option value="Colombia">Colombia</option>
<option value="Comoros">Comoros</option>
<option value="Cape Verde">Cape Verde</option>
<option value="Costa Rica">Costa Rica</option>
<option value="Cuba">Cuba</option>
<option value="Cayman Islands">Cayman Islands</option>
<option value="Cyprus">Cyprus</option>
<option value="Czech Republic">Czech Republic</option>
<option value="Germany">Germany</option>
<option value="Djibouti">Djibouti</option>
<option value="Dominica">Dominica</option>
<option value="Denmark">Denmark</option>
<option value="Dominican Republic">Dominican Republic</option>
<option value="Algeria">Algeria</option>
<option value="Ecuador">Ecuador</option>
<option value="Egypt">Egypt</option>
<option value="Eritrea">Eritrea</option>
<option value="Spain">Spain</option>
<option value="Estonia">Estonia</option>
<option value="Ethiopia">Ethiopia</option>
<option value="Finland">Finland</option>
<option value="Fiji">Fiji</option>
<option value="France">France</option>
<option value="Micronesia, Federated States of">Micronesia, Federated States of</option>
<option value="Gabon">Gabon</option>
<option value="United Kingdom">United Kingdom</option>
<option value="Georgia">Georgia</option>
<option value="Ghana">Ghana</option>
<option value="Guinea">Guinea</option>
<option value="Gambia">Gambia</option>
<option value="Guinea-Bissau">Guinea-Bissau</option>
<option value="Equatorial Guinea">Equatorial Guinea</option>
<option value="Greece">Greece</option>
<option value="Grenada">Grenada</option>
<option value="Guatemala">Guatemala</option>
<option value="Guam">Guam</option>
<option value="Guyana">Guyana</option>
<option value="Hong Kong">Hong Kong</option>
<option value="Honduras">Honduras</option>
<option value="Croatia">Croatia</option>
<option value="Haiti">Haiti</option>
<option value="Hungary">Hungary</option>
<option value="Indonesia">Indonesia</option>
<option value="India">India</option>
<option value="Ireland">Ireland</option>
<option value="Iran, Islamic Republic of">Iran, Islamic Republic of</option>
<option value="Iraq">Iraq</option>
<option value="Iceland">Iceland</option>
<option value="Israel">Israel</option>
<option value="Italy">Italy</option>
<option value="Jamaica">Jamaica</option>
<option value="Jordan">Jordan</option>
<option value="Japan">Japan</option>
<option value="Kazakhstan">Kazakhstan</option>
<option value="Kenya">Kenya</option>
<option value="Kyrgyzstan">Kyrgyzstan</option>
<option value="Cambodia">Cambodia</option>
<option value="Kiribati">Kiribati</option>
<option value="Saint Kitts and Nevis">Saint Kitts and Nevis</option>
<option value="Korea, Republic of">Korea, Republic of</option>
<option value="Kuwait">Kuwait</option>
<option value="Lao People's Democratic Republic">Lao People's Democratic Republic</option>
<option value="Lebanon">Lebanon</option>
<option value="Liberia">Liberia</option>
<option value="Libya">Libya</option>
<option value="Saint Lucia">Saint Lucia</option>
<option value="Liechtenstein">Liechtenstein</option>
<option value="Sri Lanka">Sri Lanka</option>
<option value="Lesotho">Lesotho</option>
<option value="Lithuania">Lithuania</option>
<option value="Luxembourg">Luxembourg</option>
<option value="Latvia">Latvia</option>
<option value="Morocco">Morocco</option>
<option value="Monaco">Monaco</option>
<option value="Moldova, Republic of">Moldova, Republic of</option>
<option value="Madagascar">Madagascar</option>
<option value="Maldives">Maldives</option>
<option value="Mexico">Mexico</option>
<option value="Marshall Islands">Marshall Islands</option>
<option value="Macedonia, the former Yugoslav Republic of">Macedonia, the former Yugoslav Republic of</option>
<option value="Mali">Mali</option>
<option value="Malta">Malta</option>
<option value="Myanmar">Myanmar</option>
<option value="Montenegro">Montenegro</option>
<option value="Mongolia">Mongolia</option>
<option value="Mozambique">Mozambique</option>
<option value="Mauritania">Mauritania</option>
<option value="Mauritius">Mauritius</option>
<option value="Malawi">Malawi</option>
<option value="Malaysia">Malaysia</option>
<option value="Namibia">Namibia</option>
<option value="Niger">Niger</option>
<option value="Nigeria">Nigeria</option>
<option value="Nicaragua">Nicaragua</option>
<option value="Netherlands">Netherlands</option>
<option value="Norway">Norway</option>
<option value="Nepal">Nepal</option>
<option value="Nauru">Nauru</option>
<option value="New Zealand">New Zealand</option>
<option value="Oman">Oman</option>
<option value="Pakistan">Pakistan</option>
<option value="Panama">Panama</option>
<option value="Peru">Peru</option>
<option value="Philippines">Philippines</option>
<option value="Palau">Palau</option>
<option value="Papua New Guinea">Papua New Guinea</option>
<option value="Poland">Poland</option>
<option value="Puerto Rico">Puerto Rico</option>
<option value="Korea, Democratic People's Republic of">Korea, Democratic People's Republic of</option>
<option value="Portugal">Portugal</option>
<option value="Paraguay">Paraguay</option>
<option value="Palestine, State of">Palestine, State of</option>
<option value="Qatar">Qatar</option>
<option value="Romania">Romania</option>
<option value="Russian Federation">Russian Federation</option>
<option value="Rwanda">Rwanda</option>
<option value="Saudi Arabia">Saudi Arabia</option>
<option value="Sudan">Sudan</option>
<option value="Senegal">Senegal</option>
<option value="Singapore">Singapore</option>
<option value="Solomon Islands">Solomon Islands</option>
<option value="Sierra Leone">Sierra Leone</option>
<option value="El Salvador">El Salvador</option>
<option value="San Marino">San Marino</option>
<option value="Somalia">Somalia</option>
<option value="Serbia">Serbia</option>
<option value="South Sudan">South Sudan</option>
<option value="Sao Tome and Principe">Sao Tome and Principe</option>
<option value="Suriname">Suriname</option>
<option value="Slovakia">Slovakia</option>
<option value="Slovenia">Slovenia</option>
<option value="Sweden">Sweden</option>
<option value="Swaziland">Swaziland</option>
<option value="Seychelles">Seychelles</option>
<option value="Syrian Arab Republic">Syrian Arab Republic</option>
<option value="Chad">Chad</option>
<option value="Togo">Togo</option>
<option value="Thailand">Thailand</option>
<option value="Tajikistan">Tajikistan</option>
<option value="Turkmenistan">Turkmenistan</option>
<option value="Timor-Leste">Timor-Leste</option>
<option value="Tonga">Tonga</option>
<option value="Trinidad and Tobago">Trinidad and Tobago</option>
<option value="Tunisia">Tunisia</option>
<option value="Turkey">Turkey</option>
<option value="Tuvalu">Tuvalu</option>
<option value="Taiwan, Province of China">Taiwan, Province of China</option>
<option value="Tanzania, United Republic of">Tanzania, United Republic of</option>
<option value="Uganda">Uganda</option>
<option value="Ukraine">Ukraine</option>
<option value="Uruguay">Uruguay</option>
<option value="United States">United States</option>
<option value="Uzbekistan">Uzbekistan</option>
<option value="Saint Vincent and the Grenadines">Saint Vincent and the Grenadines</option>
<option value="Venezuela, Bolivarian Republic of">Venezuela, Bolivarian Republic of</option>
<option value="Virgin Islands, British">Virgin Islands, British</option>
<option value="Virgin Islands, U.S.">Virgin Islands, U.S.</option>
<option value="Viet Nam">Viet Nam</option>
<option value="Vanuatu">Vanuatu</option>
<option value="Samoa">Samoa</option>
<option value="Yemen">Yemen</option>
<option value="South Africa">South Africa</option>
<option value="Zambia">Zambia</option>
<option value="Zimbabwe">Zimbabwe</option>
</select></span>
</p>
</div>
<div class="formFields">
<p><span class="wpcf7-form-control-wrap" data-name="RDFocus"><select class="wpcf7-form-control wpcf7-select" aria-invalid="false" name="RDFocus">
<option value="">—Please choose an option—</option>
<option value="Discovery">Discovery</option>
<option value="Pre-Clinical">Pre-Clinical</option>
<option value="Clinical">Clinical</option>
<option value="Manufacturing">Manufacturing</option>
<option value="Unknown">Unknown</option>
</select></span><br>
<span class="wpcf7-form-control-wrap" data-name="TherapeuticArea"><select class="wpcf7-form-control wpcf7-select" aria-invalid="false" name="TherapeuticArea">
<option value="">—Please choose an option—</option>
<option value="Oncology">Oncology</option>
<option value="Metabolic">Metabolic</option>
<option value="Anti-Inflammatory">Anti-Inflammatory</option>
<option value="CNS">CNS</option>
<option value="Hypoxia">Hypoxia</option>
<option value="Bone">Bone</option>
<option value="Infectious">Infectious</option>
<option value="Fertility">Fertility</option>
<option value="Cardiac">Cardiac</option>
<option value="Other">Other</option>
</select></span>
</p>
</div>
<div class="formFieldsFull">
<p><span class="wpcf7-form-control-wrap" data-name="ServicesInterestedIn"><select class="wpcf7-form-control wpcf7-select" aria-invalid="false" name="ServicesInterestedIn">
<option value="">—Please choose an option—</option>
<option value="Biomarkers">Biomarkers</option>
<option value="Cell-Based Assays">Cell-Based Assays</option>
<option value="PK Assays">PK Assays</option>
<option value="Immunogenicity">Immunogenicity</option>
<option value="Impurity Testing">Impurity Testing</option>
<option value="NAb Assays">NAb Assays</option>
<option value="Potency Testing">Potency Testing</option>
<option value="ADA Assays">ADA Assays</option>
<option value="Toxicology">Toxicology</option>
<option value="Small LCMS">Small LCMS</option>
<option value="Large LCMS">Large LCMS</option>
<option value="DMPK">DMPK</option>
<option value="Formulation">Formulation</option>
<option value="Diagnostic Testing">Diagnostic Testing</option>
<option value="Unknown">Unknown</option>
</select></span>
</p>
</div>
<div class="formFieldsFull">
<p><span class="wpcf7-form-control-wrap" data-name="Whatwouldyouliketodiscuss"><input size="40" class="wpcf7-form-control wpcf7-text" aria-invalid="false" placeholder="What would you like to discuss?" value="" type="text"
name="Whatwouldyouliketodiscuss"></span>
</p>
</div>
</div>
<p class="acceptedText">I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any
time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy. </p>
<p class="acceptanceCheckBox"><span class="wpcf7-form-control-wrap" data-name="acceptance-779"><span class="wpcf7-form-control wpcf7-acceptance"><span class="wpcf7-list-item"><label><input type="checkbox" name="acceptance-779" value="1"
aria-invalid="false"><span class="wpcf7-list-item-label">I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.</span></label></span></span></span>
</p>
<div class="formFieldsFull">
</div>
<div class="submitButton">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="gclid">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="msclkid">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="fbclid">
<p><span class="wpcf7-form-control-wrap" data-name="hcap-cf7"><span id="hcap_cf7-63e1b59e57b2f6.89691296" class="wpcf7-form-control h-captcha" data-sitekey="eceb82c5-b0aa-43ce-ae0c-e5b133a3a27e" data-theme="light"
data-size="normal"></span></span><input type="hidden" id="_wpnonce" name="_wpnonce" value="64ca938b22"><input type="hidden" name="_wp_http_referer" value="/"><input class="wpcf7-form-control has-spinner wpcf7-submit" type="submit"
value="Submit" disabled=""><span class="wpcf7-spinner"></span>
</p>
</div><input type="hidden" class="wpcf7-pum" value="{"closepopup":false,"closedelay":0,"openpopup":false,"openpopup_id":0}">
<div class="wpcf7-response-output" aria-hidden="true"></div>
</form>POST /#wpcf7-f1252-o1
<form action="/#wpcf7-f1252-o1" method="post" class="wpcf7-form init" aria-label="Contact form" novalidate="novalidate" data-status="init">
<div style="display: none;">
<input type="hidden" name="_wpcf7" value="1252">
<input type="hidden" name="_wpcf7_version" value="5.7.3">
<input type="hidden" name="_wpcf7_locale" value="en_US">
<input type="hidden" name="_wpcf7_unit_tag" value="wpcf7-f1252-o1">
<input type="hidden" name="_wpcf7_container_post" value="0">
<input type="hidden" name="_wpcf7_posted_data_hash" value="">
</div>
<p><br>
<span class="wpcf7-form-control-wrap" data-name="firstName"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" placeholder="First Name*" value="" type="text"
name="firstName"></span>
</p>
<p><br>
<span class="wpcf7-form-control-wrap" data-name="lastName"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" placeholder="Last Name*" value="" type="text"
name="lastName"></span>
</p>
<p><br>
<span class="wpcf7-form-control-wrap" data-name="email"><input size="40" class="wpcf7-form-control wpcf7-text wpcf7-email wpcf7-validates-as-required wpcf7-validates-as-email" aria-required="true" aria-invalid="false" placeholder="Email*"
value="" type="email" name="email"></span>
</p>
<div class="row">
<div class="col span_24">
<p>I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the
unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the <a target="_blank" href="/privacy/">privacy policy</a>. </p>
<p><span class="wpcf7-form-control-wrap" data-name="Opt-In"><span class="wpcf7-form-control wpcf7-checkbox wpcf7-validates-as-required"><span class="wpcf7-list-item first last"><input type="checkbox" name="Opt-In[]" value="Yes"
tabindex="0"><span class="wpcf7-list-item-label">Yes</span></span></span></span> I confirm that I am over the age of 16 and I consent to communications from BioAgilytix. </p>
</div>
</div>
<!--div class="formFieldsFull" style="margin-bottom:15px;">
[recaptcha]
</div-->
<p style="display:none;"><span class="wpcf7-form-control-wrap" data-name="referer-page"><input size="40" class="wpcf7-form-control wpcf7-text referer-page" aria-invalid="false" value="" type="text" name="referer-page"></span>
</p>
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="utm_source">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="utm_medium">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="utm_campaign">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="utm_term">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="gclid">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="msclkid">
<input class="wpcf7-form-control wpcf7-hidden" value="" type="hidden" name="fbclid">
<p><span class="wpcf7-form-control-wrap" data-name="hcap-cf7"><span id="hcap_cf7-63e1b59d040010.49928562" class="wpcf7-form-control h-captcha" data-sitekey="eceb82c5-b0aa-43ce-ae0c-e5b133a3a27e" data-theme="light"
data-size="normal"></span></span><input type="hidden" id="_wpnonce" name="_wpnonce" value="64ca938b22"><input type="hidden" name="_wp_http_referer" value="/"><input class="wpcf7-form-control has-spinner wpcf7-submit" type="submit"
value="Subscribe to Newsletter"><span class="wpcf7-spinner"></span>
</p><input type="hidden" class="wpcf7-pum" value="{"closepopup":false,"closedelay":0,"openpopup":false,"openpopup_id":0}">
<div class="wpcf7-response-output" aria-hidden="true"></div>
<input type="hidden" name="pum_form_popup_id" value="35907">
</form>Text Content
Skip to content
*
*
*
*
*
Search
Close
Search
Menu
* Services
* Services
* BioAgilytix Diagnostics
* Biomarker Menu
* DMPK Assays
* Dose Formulation Analysis
* Method Development & Validation
* Pharmacokinetic Analysis And Reports
* Protein Binding Assays
* Small Molecule Bioanalysis
* Specimen Collection Kits
* Solutions
* Antibody Drug Conjugates
* Biosimilars
* CAR-T Cell Therapy
* Gene Therapy
* Immuno-Oncology
* Modified & Novel Vehicles For Gene Therapy
* Vaccines
* Assay Focus
* Assay Focus
* Biomarkers
* Cell-Based Assays
* Immunogenicity
* Pharmacokinetics
* Toxicology Studies
* Process Management
* Process Management
* Agricultural Biotechnology
* Data Management
* Industries Served
* Pharma & Biotech
* Project Management
* Sample Management
* Therapeutic Area Expertise
* Therapeutic Area Expertise
* Autoimmune
* Metabolic
* Neurology
* Oncology
* Virology
* Technology
* Our Platforms
* ELISA
* MSD-ECL
* Flow Cytometry
* Quantitative Real-Time PCR (qPCR)
* Roche cobas Analyzer
* Gyrolab
* Ella
* LI-COR Odyssey
* Luminex
* Biacore
* ImmunoCAP
* ELISpot
* Automation
* Company
* About Us
* Our Capabilities
* Meet Our Team
* Industries Served
* Awards
* Mission Vision & Values
* Meet Our Partners
* The BioAgilytix Way
* Our Quality Commitment
* US Headquarters
* European Headquarters
* Australian Headquarters
* Resources
* Resources
* Gene & Cell Therapy Center
* Testimonials
* Science In 60
* Our Blog
* News
* Case Studies
* Molecular Moments Podcast
* FAQ
* Glossary
* Articles
* Podcasts
* Events
* Webinars
* EBooks
* Infographics
* Videos
* Guidance
* Posters
* Brochures
* Papers
* News
* News
* Press Kit
* Careers
* Careers at BioAgilytix
* Why BioAgilytix
* Who Is Our Team
* How You’ll Benefit
* What You’ll Enable
SPEAK TO A SCIENTIST
* Services
SERVICES
BIOAGILYTIX DIAGNOSTICS
BIOMARKER MENU
DMPK ASSAYS
DOSE FORMULATION ANALYSIS
METHOD DEVELOPMENT & VALIDATION
OUR CAPABILITIES
PHARMACOKINETIC ANALYSIS & REPORTS
PROTEIN BINDING ASSAYS
SMALL MOLECULE BIOANALYSIS
SPECIMEN COLLECTION KITS
SOLUTIONS
ANTIBODY DRUG CONJUGATES
BIOSIMILARS
CAR-T CELL THERAPY
GENE THERAPY
IMMUNO-ONCOLOGY
MODIFIED & NOVEL VEHICLES FOR GENE THERAPY
VACCINES
ASSAY FOCUS
BIOMARKERS
CELL-BASED ASSAYS
IMMUNOGENICITY
PHARMACOKINETICS
TOXICOLOGY STUDIES
PROCESS MANAGEMENT
AGRICULTURAL BIOTECHNOLOGY
DATA MANAGEMENT
INDUSTRIES SERVED
PHARMA & BIOTECH
PROJECT MANAGEMENT
SAMPLE MANAGEMENT
THERAPEUTIC AREA EXPERTISE
AUTOIMMUNE
METABOLIC
NEUROLOGY
ONCOLOGY
VIROLOGY
* Technology
OUR PLATFORMS
LEARN MORE
QUANTSTUDIO 7 FLEX
(qPCR)
LUMINEX FLEXMAP 3D
(Luminex)
FLOW CYTOMETRY
ROCHE COBAS® E411 ANALYZER
(Automated Immunoassays)
MESO SCALE DISCOVERY SECTOR S600, AND QUICKPLEX SQ 120
(MSD-Multiplex ECLIA)
BIACORE T200™
(SPR Biomarker Interactions)
PHADIA 200
(ImmunoCAP)
LI-COR ODYSSEY
(Western Blot Imager)
ELISPOT READER
(Immune Cell Cytokine Release)
GYROLAB™
(Low Volume Automated ELISA)
PROTEINSIMPLE ELLA
(Multiplex Immunoassay)
BIOTEK SYNERGY NE02 PLATE READER
(ELISA)
DDPCR
Droplet Digital PCR QX200, QX One
AUTOMATION
LEARN MORE
HAMILTON MICROLAB® NIMBUS
HAMILTON MICROLAB® STARLET
BIOMEK FXP
BIOTEK MICROPLATE WASHER
BIOTEK PRECISION™ 2000
BIOTEK MULTIFLO™ FX
PERKIN ELMER JANUS G3 LIQUID HANDLER
MANTIS
INTEGRA ASSIST PLUS
YOUR PARTNER FOR GLOBAL BIOANALYTICAL SERVICES
Delivering Premier Science, Deep Experience, and Proven Quality
* Company
ABOUT US
OUR CAPABILITIES
MEET OUR TEAM
INDUSTRIES SERVED
AWARDS & CERTIFICATIONS
MISSION VISION & VALUES
MEET OUR PARTNERS
THE BIOAGILYTIX WAY
OUR QUALITY COMMITMENT
AUSTRALIAN ADVANTAGE
CLICK ON LOCATION TO LEARN MORE
SAN DIEGO LAB
~34,000 sq. ft.
CRO
Immunoassay
Mass Spectrometry
USA HQ (DURHAM)
~265,000 sq. ft.
Discovery
Preclinical/clinal
Manufacturing
BOSTON LAB
~22,000 sq. ft.
Bioanalytical Services
Diagnostic Testing
EUROPEAN HQ (HAMBURG)
~2,900 m2 (31,000 sq. ft.)
Assay Development
Validation
Sample Analysis
Global Disease Studies
MELBOURNE LAB
2,777 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
BRISBANE LAB
1,566 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
SPEAK TO OUR TEAM
Explore the capabilities of each platform in more detail to learn which
option will be best for your unique study. Our team is available for specific
guidance on platform selection.
* Resources
RESOURCES
GENE & CELL THERAPY CENTER
TESTIMONIALS
OUR BLOG
NEWS
CASE STUDIES
MOLECULAR MOMENTS PODCAST
SCIENCE IN 60
FAQ
GLOSSARY
SCIENTIFIC POSTERS
RESOURCE CENTER
ARTICLES
PODCASTS
EVENTS
WEBINARS
EBOOKS
INFOGRAPHICS
VIDEOS
GUIDANCE
POSTERS
BROCHURES
PAPERS
[EPISODE 24] DR. DAVID BERKOWITZ TALKS ENZYMES, RADIATION, AND THE LINCOLN
MARATHON
January 6, 2023
On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David
Berkowitz, Director of the Division of Chemistry at
SHARE THIS
Read More »
IMMUNOGENICITY TESTING FOR BIOSIMILARS
December 19, 2022
Entering the biosimilars market is an enticing prospect for many biopharma
companies, offering the potential for reduced development and manufacturing
SHARE THIS
Read More »
BIOANALYTICAL NEEDS AND BIOSIMILARS: HOW DOES THE MOLECULE COMPARE?
January 3, 2023
Once the patent on a previously ground-breaking blockbuster molecule comes to
an end, there is an opportunity for biosimilar versions
SHARE THIS
Read More »
TRENDS PAVING THE WAY FOR AN INFLUX OF BIOSIMILAR DEVELOPMENT
January 3, 2023
Promising broader patient access to critical medicines, biosimilars offer a
more cost-effective alternative therapeutic option compared with originator
products. With
SHARE THIS
Read More »
* News
RECENT NEWS
BIOAGILYTIX EXPANDS TO SECOND CAMPUS IN DURHAM, NC
October 19, 2022
78,000 Square Feet of Lab and Office Space Added in the First of a
Multi-Phase Expansion Durham, NC, October 19,
SHARE THIS
Read More »
BIOAGILYTIX ANNOUNCES APPOINTMENT OF DR. LINDA ROBBIE AS CHIEF OPERATING
OFFICER
August 17, 2022
Durham, NC, August 17, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading
contract research organization supporting pharmaceutical and biotech partners
in
SHARE THIS
Read More »
EVENTS
PRESS KIT
RECENT NEWS
IMMUNOGENICITY TESTING FOR BIOSIMILARS
December 19, 2022
Entering the biosimilars market is an enticing prospect for many biopharma
companies, offering the potential for reduced development and manufacturing
SHARE THIS
Read More »
THE STATE OF THE BIOSIMILARS MARKET
December 13, 2022
3 key challenges facing the biosimilars space in 2023 In 2010, the biopharma
industry saw an abrupt patent cliff: a
SHARE THIS
Read More »
HOW HAVE ADVANCED DRUG MODALITIES IMPACTED BIOANALYSIS?
November 22, 2022
As therapeutic drugs have grown in complexity, so too have the bioanalysis
techniques to support these products. Bioanalysis of small molecule
SHARE THIS
Read More »
EVENTS
* Careers
CAREERS
View Current Career Opportunities
WHY
BIOAGILYTIX
Because the best science
demands the best people.
Read More
WHO
IS ON OUR TEAM
Meet our Global Colleagues.
Read More
HOW
YOU’LL BENEFIT
Explore our benefit program
and company perks.
Read More
WHAT
YOU’LL ENABLE
See how your work will
change patients’ lives.
Read More
CAREERS
WHY BIOAGILYTIX
WHO IS ON OUR TEAM
HOW YOU’LL BENEFIT
WHAT YOU’LL ENABLE
CURRENT OPPORTUNITIES
COMPANY
* Services
SERVICES
BIOAGILYTIX DIAGNOSTICS
BIOMARKER MENU
DMPK ASSAYS
DOSE FORMULATION ANALYSIS
METHOD DEVELOPMENT & VALIDATION
OUR CAPABILITIES
PHARMACOKINETIC ANALYSIS & REPORTS
PROTEIN BINDING ASSAYS
SMALL MOLECULE BIOANALYSIS
SPECIMEN COLLECTION KITS
SOLUTIONS
ANTIBODY DRUG CONJUGATES
BIOSIMILARS
CAR-T CELL THERAPY
GENE THERAPY
IMMUNO-ONCOLOGY
MODIFIED & NOVEL VEHICLES FOR GENE THERAPY
VACCINES
ASSAY FOCUS
BIOMARKERS
CELL-BASED ASSAYS
IMMUNOGENICITY
PHARMACOKINETICS
TOXICOLOGY STUDIES
PROCESS MANAGEMENT
AGRICULTURAL BIOTECHNOLOGY
DATA MANAGEMENT
INDUSTRIES SERVED
PHARMA & BIOTECH
PROJECT MANAGEMENT
SAMPLE MANAGEMENT
THERAPEUTIC AREA EXPERTISE
AUTOIMMUNE
METABOLIC
NEUROLOGY
ONCOLOGY
VIROLOGY
* Technology
OUR PLATFORMS
LEARN MORE
QUANTSTUDIO 7 FLEX
(qPCR)
LUMINEX FLEXMAP 3D
(Luminex)
FLOW CYTOMETRY
ROCHE COBAS® E411 ANALYZER
(Automated Immunoassays)
MESO SCALE DISCOVERY SECTOR S600, AND QUICKPLEX SQ 120
(MSD-Multiplex ECLIA)
BIACORE T200™
(SPR Biomarker Interactions)
PHADIA 200
(ImmunoCAP)
LI-COR ODYSSEY
(Western Blot Imager)
ELISPOT READER
(Immune Cell Cytokine Release)
GYROLAB™
(Low Volume Automated ELISA)
PROTEINSIMPLE ELLA
(Multiplex Immunoassay)
BIOTEK SYNERGY NE02 PLATE READER
(ELISA)
DDPCR
Droplet Digital PCR QX200, QX One
AUTOMATION
LEARN MORE
HAMILTON MICROLAB® NIMBUS
HAMILTON MICROLAB® STARLET
BIOMEK FXP
BIOTEK MICROPLATE WASHER
BIOTEK PRECISION™ 2000
BIOTEK MULTIFLO™ FX
PERKIN ELMER JANUS G3 LIQUID HANDLER
MANTIS
INTEGRA ASSIST PLUS
YOUR PARTNER FOR GLOBAL BIOANALYTICAL SERVICES
Delivering Premier Science, Deep Experience, and Proven Quality
* Company
ABOUT US
OUR CAPABILITIES
MEET OUR TEAM
INDUSTRIES SERVED
AWARDS & CERTIFICATIONS
MISSION VISION & VALUES
MEET OUR PARTNERS
THE BIOAGILYTIX WAY
OUR QUALITY COMMITMENT
AUSTRALIAN ADVANTAGE
CLICK ON LOCATION TO LEARN MORE
SAN DIEGO LAB
~34,000 sq. ft.
CRO
Immunoassay
Mass Spectrometry
USA HQ (DURHAM)
~265,000 sq. ft.
Discovery
Preclinical/clinal
Manufacturing
BOSTON LAB
~22,000 sq. ft.
Bioanalytical Services
Diagnostic Testing
EUROPEAN HQ (HAMBURG)
~2,900 m2 (31,000 sq. ft.)
Assay Development
Validation
Sample Analysis
Global Disease Studies
MELBOURNE LAB
2,777 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
BRISBANE LAB
1,566 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
SPEAK TO OUR TEAM
Explore the capabilities of each platform in more detail to learn which
option will be best for your unique study. Our team is available for specific
guidance on platform selection.
* Resources
RESOURCES
GENE & CELL THERAPY CENTER
TESTIMONIALS
OUR BLOG
NEWS
CASE STUDIES
MOLECULAR MOMENTS PODCAST
SCIENCE IN 60
FAQ
GLOSSARY
SCIENTIFIC POSTERS
RESOURCE CENTER
ARTICLES
PODCASTS
EVENTS
WEBINARS
EBOOKS
INFOGRAPHICS
VIDEOS
GUIDANCE
POSTERS
BROCHURES
PAPERS
[EPISODE 24] DR. DAVID BERKOWITZ TALKS ENZYMES, RADIATION, AND THE LINCOLN
MARATHON
January 6, 2023
On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David
Berkowitz, Director of the Division of Chemistry at
SHARE THIS
Read More »
IMMUNOGENICITY TESTING FOR BIOSIMILARS
December 19, 2022
Entering the biosimilars market is an enticing prospect for many biopharma
companies, offering the potential for reduced development and manufacturing
SHARE THIS
Read More »
BIOANALYTICAL NEEDS AND BIOSIMILARS: HOW DOES THE MOLECULE COMPARE?
January 3, 2023
Once the patent on a previously ground-breaking blockbuster molecule comes to
an end, there is an opportunity for biosimilar versions
SHARE THIS
Read More »
TRENDS PAVING THE WAY FOR AN INFLUX OF BIOSIMILAR DEVELOPMENT
January 3, 2023
Promising broader patient access to critical medicines, biosimilars offer a
more cost-effective alternative therapeutic option compared with originator
products. With
SHARE THIS
Read More »
* News
RECENT NEWS
BIOAGILYTIX EXPANDS TO SECOND CAMPUS IN DURHAM, NC
October 19, 2022
78,000 Square Feet of Lab and Office Space Added in the First of a
Multi-Phase Expansion Durham, NC, October 19,
SHARE THIS
Read More »
BIOAGILYTIX ANNOUNCES APPOINTMENT OF DR. LINDA ROBBIE AS CHIEF OPERATING
OFFICER
August 17, 2022
Durham, NC, August 17, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading
contract research organization supporting pharmaceutical and biotech partners
in
SHARE THIS
Read More »
EVENTS
PRESS KIT
RECENT NEWS
IMMUNOGENICITY TESTING FOR BIOSIMILARS
December 19, 2022
Entering the biosimilars market is an enticing prospect for many biopharma
companies, offering the potential for reduced development and manufacturing
SHARE THIS
Read More »
THE STATE OF THE BIOSIMILARS MARKET
December 13, 2022
3 key challenges facing the biosimilars space in 2023 In 2010, the biopharma
industry saw an abrupt patent cliff: a
SHARE THIS
Read More »
HOW HAVE ADVANCED DRUG MODALITIES IMPACTED BIOANALYSIS?
November 22, 2022
As therapeutic drugs have grown in complexity, so too have the bioanalysis
techniques to support these products. Bioanalysis of small molecule
SHARE THIS
Read More »
EVENTS
* Careers
CAREERS
View Current Career Opportunities
WHY
BIOAGILYTIX
Because the best science
demands the best people.
Read More
WHO
IS ON OUR TEAM
Meet our Global Colleagues.
Read More
HOW
YOU’LL BENEFIT
Explore our benefit program
and company perks.
Read More
WHAT
YOU’LL ENABLE
See how your work will
change patients’ lives.
Read More
CAREERS
WHY BIOAGILYTIX
WHO IS ON OUR TEAM
HOW YOU’LL BENEFIT
WHAT YOU’LL ENABLE
CURRENT OPPORTUNITIES
COMPANY
BIOLOGY.
AGILITY.
ANALYTICS.
Our relentless dedication to accuracy, timeliness and regulatory rigor enables
your therapeutic innovations to reach patients faster. We’ve succeeded in
delivering many life-saving therapeutics on-time and in scope. These
therapeutics have earned market approval, with bioanalytical testing provided by
BioAgilytix.
More About Us
PATIENTS ARE PEOPLE
The better we do our job, the faster you can help patients in need. We’ve
succeeded in delivering many life-saving therapeutics on-time and in-scope.
These therapeutics have earned FDA approval, with assay samples validated by
BioAgilytix in under 2 months.
More About Us
HOW WE WORK
SERVICES DELIVERED SCIENTIST TO SCIENTIST
Our fully integrated GxP services are driven by your assay requirements and
delivered by our veteran scientists – collaboratively, accurately, and on-time.
canadian online pharmacy no prescription online pharmacy canada
SEE HOW WE WORK
BIOMARKERS
IMMUNOGENICITY
CELL-BASED ASSAYS
PHARMACOKINETICS
& PHARMACODYNAMICS (PK/PD)
BIOSIMILARS
GENE THERAPY
ANTIBODY DRUG
CONJUGATES (ADCS)
IMMUNO-ONCOLOGY
MEET OUR SCIENTISTS
SOLUTIONS ENABLED BY GLOBALLY RECOGNIZED EXPERTS
Our team is comprised of industry leaders who bring innovation to the complex
and evolving landscape of biotherapeutics.
EXPLORE SOLUTIONS
ADVANCED BIOANALYTICAL LAB FACILITIES TO SUPPORT ALL PHASES OF DRUG DEVELOPMENT.
Explore Our USA Headquarters
BioAgilytix has locations in three of the leading biotech and pharmaceutical
areas in the United States. Our headquarters is located in the Research Triangle
Park area of North Carolina where we combine specialized expertise,
state-of-the-art technology, and deep regulatory knowledge to provide
high-quality immunoassay support. Our second location in Boston is located in
the heart of the world’s biotech innovation hub and boasts a 20-plus-year track
record of delivering premier bioanalytical services with specialized diagnostic
testing. Our third US location in the Sorrento Valley area of San Diego also
boasts over two decades of experience in supporting DMPK, bioanalysis, and
pharmacokinetic analysis.
Explore Our European Lab
BioAgilytix’s advanced laboratory facilities in Hamburg, Germany, serve as our
European headquarters, offering a breadth and depth of services, technology, and
expertise specifically for large molecule bioanalysis.
Explore Our Australian Labs
BioAgilytix has two locations within Australia. Our Melbourne laboratory is
located in Australia’s biomedical and clinical research hub and is co-located
with the world-class Burnet Institute, Australia’s largest Phase 1 unit, which
makes us uniquely situated to support all your clinical needs. Our second
facility is in Brisbane and is located in the Translational Research Institute
(TRI) in Woolloongabba, whose vision is to be a global leader in the effective
translation of research and innovation into improved healthcare. This focus on
‘bench to bedside’ is consistent with the BioAgilytix mission of enabling future
medicines.
SCIENCE ON-DEMAND
ADA ASSESSMENT FOR CELL THERAPIES
Cell therapies are emerging and evolving as promising therapies for a variety of
disease indications. The ability to detect anti-drug antibodies (ADA) is
important for patients receiving cell-based therapies. However, approaches to
detecting ADAs against cell-surface biotherapeutics vary utilizing either
traditional ligand binding assays or cell-based binding assays. Both ADA assay
approaches have been utilized but there is no current regulatory guidance on
which format is more appropriate for these therapeutics. In this presentation,
we will discuss the challenges of both approaches and current industry
practices.
online pharmacy canada no prescription pharmacy canada online
Watch Now
DR. DAVID BERKOWITZ TALKS ENZYMES, RADIATION, AND THE LINCOLN MARATHON
LISTEN
HOW DO YOU USE MSD U-PLEX ASSAY TECHNOLOGY FOR BIOMARKER MULTIPLEXING
View
POTENCY ASSAYS FOR ATMPS — CONCEPTION, DEVELOPMENT, VALIDATION, MATRIXED
APPROACHES AND ASSAY LIFECYCLE
View
EXPLORE OUR RESOURCE CENTER
THE BIOAGILYTIX PERSPECTIVE
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more
about our scientists’ expertise through case studies, blogs, industry articles
and other scientific resources.
View Resources
QUICK LINKS TO OUR LATEST CONTENT OFFERINGS:
IMMUNOGENICITY TESTING FOR BIOSIMILARS
Read More »
THE STATE OF THE BIOSIMILARS MARKET
Read More »
HOW HAVE ADVANCED DRUG MODALITIES IMPACTED BIOANALYSIS?
Read More »
SPEAK TO A SCIENTIST
—Please choose an option—AlabamaAlaskaAlbertaArkansasBritish
ColumbiaCaliforniaColoradoConnecticutDelawareDistrict Of
ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineManitobaMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew
BrunswickNew HampshireNew JerseyNew MexicoNew YorkNewfoundlandNorth
CarolinaNorth DakotaNorthwest TerritoriesNova
ScotiaNunavutOhioOklahomaOntarioOregonPennsylvaniaPrince Edward
IslandQuebecRhode IslandSaskatchewanSouth CarolinaSouth
DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest
VirginiaWisconsinWyomingYukon—Please choose an
option—ArubaAfghanistanAngolaAlbaniaAndorraUnited Arab
EmiratesArgentinaArmeniaAmerican SamoaAntigua and
BarbudaAustraliaAustriaAzerbaijanBurundiBelgiumBeninBurkina
FasoBangladeshBulgariaBahrainBahamasBosnia and
HerzegovinaBelarusBelizeBermudaBolivia, Plurinational State
ofBrazilBarbadosBrunei DarussalamBhutanBotswanaCentral African
RepublicCanadaSwitzerlandChileChinaCôte d'IvoireCameroonCongo, the Democratic
Republic of theCongoCook IslandsColombiaComorosCape VerdeCosta RicaCubaCayman
IslandsCyprusCzech RepublicGermanyDjiboutiDominicaDenmarkDominican
RepublicAlgeriaEcuadorEgyptEritreaSpainEstoniaEthiopiaFinlandFijiFranceMicronesia,
Federated States ofGabonUnited
KingdomGeorgiaGhanaGuineaGambiaGuinea-BissauEquatorial
GuineaGreeceGrenadaGuatemalaGuamGuyanaHong
KongHondurasCroatiaHaitiHungaryIndonesiaIndiaIrelandIran, Islamic Republic
ofIraqIcelandIsraelItalyJamaicaJordanJapanKazakhstanKenyaKyrgyzstanCambodiaKiribatiSaint
Kitts and NevisKorea, Republic ofKuwaitLao People's Democratic
RepublicLebanonLiberiaLibyaSaint LuciaLiechtensteinSri
LankaLesothoLithuaniaLuxembourgLatviaMoroccoMonacoMoldova, Republic
ofMadagascarMaldivesMexicoMarshall IslandsMacedonia, the former Yugoslav
Republic
ofMaliMaltaMyanmarMontenegroMongoliaMozambiqueMauritaniaMauritiusMalawiMalaysiaNamibiaNigerNigeriaNicaraguaNetherlandsNorwayNepalNauruNew
ZealandOmanPakistanPanamaPeruPhilippinesPalauPapua New GuineaPolandPuerto
RicoKorea, Democratic People's Republic ofPortugalParaguayPalestine, State
ofQatarRomaniaRussian FederationRwandaSaudi ArabiaSudanSenegalSingaporeSolomon
IslandsSierra LeoneEl SalvadorSan MarinoSomaliaSerbiaSouth SudanSao Tome and
PrincipeSurinameSlovakiaSloveniaSwedenSwazilandSeychellesSyrian Arab
RepublicChadTogoThailandTajikistanTurkmenistanTimor-LesteTongaTrinidad and
TobagoTunisiaTurkeyTuvaluTaiwan, Province of ChinaTanzania, United Republic
ofUgandaUkraineUruguayUnited StatesUzbekistanSaint Vincent and the
GrenadinesVenezuela, Bolivarian Republic ofVirgin Islands, BritishVirgin
Islands, U.S.Viet NamVanuatuSamoaYemenSouth AfricaZambiaZimbabwe
—Please choose an option—DiscoveryPre-ClinicalClinicalManufacturingUnknown
—Please choose an
option—OncologyMetabolicAnti-InflammatoryCNSHypoxiaBoneInfectiousFertilityCardiacOther
—Please choose an option—BiomarkersCell-Based AssaysPK
AssaysImmunogenicityImpurity TestingNAb AssaysPotency TestingADA
AssaysToxicologySmall LCMSLarge LCMSDMPKFormulationDiagnostic TestingUnknown
I consent to receive communications (which may include, phone, email, social,
and re-targeting ads) from BioAgilytix. I understand I may proactively manage my
preferences or opt-out of communications with BioAgilytix at any time using the
unsubscribe link provided in all of BioAgilytix’s email communications and can
learn more by reading the privacy policy.
I confirm that I am over the age of 16 and I consent to communications from
BioAgilytix.
CONTACT US
↑
*
*
*
*
*
USA HQ
2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099
SAN DIEGO LABORATORY
9050 Camino Santa Fe
San Diego, CA 92121
858-652-4600
Fax 858-652-4699
BRISBANE LABORATORY
37 Kent St, Woolloongabba
Queensland, 4102, Australia
*
*
*
*
*
Subscribe to Our Newsletter
USA HQ
2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099
SAN DIEGO LABORATORY
9050 Camino Santa Fe
San Diego, CA 92121
858-652-4600
Fax 858-652-4699
BRISBANE LABORATORY
37 Kent St,Woolloongabba
Queensland, 4102, Australia
BOSTON LABORATORY
1320 Soldiers Field Road
Boston, MA, 02135
617-456-0700
Fax 617-456-0701
BOSTON LABORATORY
1320 Soldiers Field Road
Boston, MA, 02135
617-456-0700
Fax 617-456-0701
EUROPEAN HQ
Lademannbogen 10
22339 Hamburg Germany
+49 405267790
MELBOURNE LABORATORY
85 Commercial Road, Melbourne
Victoria, 3004, Australia
+61 3 9282 2184
Copyright © 2023 BioAgilytix Labs. All rights reserved. Terms of Use | Privacy
Notice
EUROPEAN HQ
Lademannbogen 10
22339 Hamburg Germany
+49 405267790
MELBOURNE LABORATORY
85 Commercial Road, Melbourne
Victoria, 3004, Australia
+61 3 9282 2184
Subscribe to Our Newsletter
Copyright © 2023 BioAgilytix Labs.
All rights reserved.
CONTACT US
↑
*
*
*
*
*
DURHAM LAB (USA HQ)
2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099
MORRISVILLE LAB
5927 S. Miami Blvd. Suite 100
Morrisville, NC 27703
919-381-6097
Fax 919-381-6099
BOSTON LAB
1320 Soldiers Field Road
Boston, MA, 02135
Office 617-456-0700
Fax 617-456-0701
SAN DIEGO LAB
9050 Camino Santa Fe
San Diego, CA 92121
858-652-4600
Fax 858-652-4699
HAMBURG LAB (EU HQ)
Lademannbogen 10
22339 Hamburg Germany
+49 405267790
BRISBANE LAB
37 Kent St, Woolloongabba
Queensland, 4102, Australia
MELBOURNE LAB
85 Commercial Road, Melbourne
Victoria, 3004, Australia
03 9282 2184
*
*
*
*
*
Subscribe to Our Newsletter
Copyright © 2023 BioAgilytix Labs.
All rights reserved.
Terms of Use | Privacy Notice
DURHAM LAB (USA HQ)
2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099
MORRISVILLE LAB
5927 S. Miami Blvd. Suite 100
Morrisville, NC 27703
919-381-6097
Fax 919-381-6099
BOSTON LAB
1320 Soldiers Field Road
Boston, MA, 02135
617-456-0700
Fax 617-456-0701
SAN DIEGO LAB
9050 Camino Santa Fe
San Diego, CA 92121
858-652-4600
Fax 858-652-4699
EUROPEAN HQ
Lademannbogen 10
22339 Hamburg Germany
+49 405267790
BRISBANE LAB
37 Kent St,Woolloongabba
Queensland, 4102, Australia
MELBOURNE LAB
85 Commercial Road, Melbourne
Victoria, 3004, Australia
03 9282 2184
Subscribe to Our Newsletter
Copyright © 2023 BioAgilytix Labs.
All rights reserved.
THANK YOU!
YOU CAN ACCESS THE RECORDING AT:
Click Here to View
×
SUBSCRIBE TO OUR NEWSLETTER
I consent to receive communications (which may include, phone, email, social,
and re-targeting ads) from BioAgilytix. I understand I may proactively manage my
preferences or opt-out of communications with BioAgilytix at any time using the
unsubscribe link provided in all of BioAgilytix’s email communications and can
learn more by reading the privacy policy.
Yes I confirm that I am over the age of 16 and I consent to communications from
BioAgilytix.
×